WHO “Hydroxychloroquine” clinical trial reopened New Corona June 4, 6:46
WHO = The World Health Organization has suspended clinical trials for therapeutic agents such as malaria, which has been pointed out to be potentially effective for the treatment of new coronaviruses, but the mortality rate has been reduced by administration of the drug. Assuming there is no data to go up, it will be restarted.
A therapeutic drug for malaria, such as "hydroxychloroquine," has been pointed out to be effective for the treatment of the new coronavirus, and WHO has conducted clinical trials. In response to the announcement of research results that some of the heartbeat abnormalities were seen, on the 25th of last month, it was revealed that the clinical trial was discontinued, and safety data has been investigated.
WHO Executive Secretary Tedros said in a regular press conference at his headquarters in Geneva, Switzerland on Wednesday that "the Commission overseeing the safety of clinical trials recommends that there is no reason to change plans. In response, we decided to continue the clinical trial that included hydroxychloroquine."
WHO Chief Scientist Swaminathan said the administration of the drug did not change mortality.
In addition, Executive Secretary Tedros said that the number of newly confirmed infections has exceeded 100,000 for the past five consecutive days, ``In the past few weeks, the number of new infections in the Americas has been , The number of new cases in Europe has continued to decline, and the number reported yesterday was the lowest since March 22nd," he said. It has revealed that it has returned to the level it was before the outbreak spread in Europe.
At the press conference... Questions about the relationship with China
The Associated Press reported on the 2nd, and although WHO was dissatisfied with China's response, it seemed to have taken an attitude of valuing China ostensibly to obtain cooperation, and recorded the meeting that it acquired independently. Based on inside information, at the WHO regular press conference on the 3rd, many questions were asked about this point.
Regarding this, Mr. Ryan, who is in charge of crisis response, said, "I would like to convey that, according to WHO rules, I have worked equally day and night to support member countries and share information."
Questions about insider information continued, but spokesperson Yaslavevich, who moderated the interview, said, "I have already answered, so let's move on to the next question," and refused to accept additional questions. did.